Features of the pregnancy and delivery course, fetal and newborn status in women with COVID-19





pregnancy, COVID-19, SARS CoV-2.


Research objective. To evaluate the features of pregnancy and delivery course, fetal and newborn status in women with confirmed COVID-19.
Materials and methods. A retrospective clinical and statistical analysis of 106 pregnancy and delivery case histories and medical records of newborn from women with a gestation period of 22–41 weeks with a confirmed diagnosis
of COVID-19 was carried out. Women were treated and delivered on the temporarily converted beds for providing obstetric care to pregnant women, women in labor and postpartum women with suspected and infected COVID-19 and gynecological patients of Municipal Non-Profit Enterprise “Kyiv City Maternity Hospital No. 3” from September 2020 to May 2021.
Results. Delivery took place in 48 women. Women with A (II) blood group were significantly predominant – 51 (48.1%) and rhesus-positive factor – 85 (80.2%) (p < 0.05). One third of pregnant women sought medical help on their own – 34 (32.1%). 94 (88.7%) women had a positive PCR test, in 6 (11.3%) cases the diagnosis was confirmed by a rapid test in the admission department; in 6 (11.3%) cases the test results were negative. The leading complaints when pregnant women were hospitalized were fever, cough and fatigue in 85 (80.2%), 90 (84.9%) and 73 (68.9%) pregnant women respectively (p < 0.05). Almost every third woman (39, 36.8%) had a subfebrile temperature – 37.0–37.5 oC. In 15 (14.1%) patients the temperature was 38.0–38.5 oC, in 6 (5.7%) patients over 38.5 oC. At the lung ultrasound the signs of bilateral and polysegmental pneumonia were diagnosed in 44 (53.6%) and 36 (43.9%) cases. Lower and upper lobe pneumonia was diagnosed in 20 (24.4%) pregnant women. Severe lung damage was detected in 29 (35.4%) pregnant women in the form of partial “hepatization” of lung tissue, pleural effusion in the form of black areas of various sizes in the pleural cavity.
Conclusions. The main typical SARS CoV-2 complaints in hospitalized pregnant women were fever, cough, fatigue and shortness of breath at rest and during exercise. Such neurological manifestations of SARS CoV-2 as headache, anosmia were noted by almost every third pregnant woman, and parosmia and myalgia were noted by every fourth pregnant woman. The average level of C-reactive protein was above normal in 97.2% of women. Lung ultrasound allowed clearly identifying areas of damage and determining the degree of lung tissue damage.

Author Biographies

V.O. Beniuk, Bogomolets National Medical University, Kyiv

MD, professor, head of the Obstetrics and Gynecology Department No. 3

N.M. Hychka, Bogomolets National Medical University; Kyiv City Maternity Hospital No. 3, Kyiv

PhD, associate professor, Obstetrics and Gynecology Department No. 3;

O.V. Zabudskyi, Bogomolets National Medical University; Kyiv City Maternity Hospital No. 3, Kyiv

PhD, associate professor, Obstetrics and Gynecology Department No. 3;
Responsible for organizing and providing of obstetric care to patients who are in deployed intensive care beds for the treatment of patients with coronavirus disease COVID-19

T.M. Fursa-Sovhyra, Bogomolets National Medical University; Kyiv City Maternity Hospital No. 3, Kyiv

Assistant, Obstetrics and Gynecology Department No. 3;
Deputy director for organizational and methodological work

T.V. Kovaliuk, Bogomolets National Medical University, Kyiv

PhD, associate professor, Obstetrics and Gynecology Department No. 3

V.F. Oleshko, Bogomolets National Medical University, Kyiv

PhD, assistant, Obstetrics and Gynecology Department No. 3

A.S. Chebotarova, Bogomolets National Medical University, Kyiv

Assistant, Obstetrics and Gynecology Department No. 3


  1. Abaturov, A.E., Agafonova, E.A., Krivusha, E.L., Nikulina, A.A. “Pathogenesis of COVID-19.” Child’s Health 15.3 (2020): 133–44.
  2. Bezhenar, V.F., Ailamazian, E.K., Zazerskaia, I.E. Brief clinical recommendations. Tactics for the management of pregnant women, women in labor and maternity patients with suspected or confirmed COVID-19 infection. Eco-Vector (2020): 47 p. DOI: 10.17816/JOWDS20201
  3. Ministry of Health of Ukraine. Order No. 722 from 28.03.2020 “Organization of medical care for patients with coronavirus disease (COVID-19)” (as amended by orders of the Ministry of health of Ukraine No. 827 from 09.04.2020, No. 953 from 23.04.2020, No. 994 from 30.04.2020).
  4. Ministry of Health of Ukraine. Operational information on the spread and Prevention of COVID-19. Available from: [https://moz.gov.ua/].
  5. Rekalova, O.M. “COVID-19 – a new viral infection: pathogenesis, diagnosis, treatment.” Tuberculosis, Lung Diseases, HIV Infection 2.41 (2020): 7–16.
  6. Turianytsia, S.M., Korchynska, O.O., Sabova, A.V., et al. “Effect of acute respiratory viral disease SARS-CoV-19 on the course of pregnancy and childbirth.” Reproductive Health of Woman 2.47 (2021): 15–8. DOI: 10.30841/2708-8731.2.2021.232515
  7. Centers for Disease Control and Prevention. Interim guidance for implementing home care of people not requiring hospitalization for 2019 novel coronavirus (2019-nCoV). Updated Jan. 31, 2020. Available from: [https://www.cdc.gov/ coronavirus/2019-ncov/hcp/guidance- homecare.html?CDC_AA_refVal¼https%3A%2F% 2Fwww.cdc.gov%2Fcoronavirus%2F2019- ncov%2Fguidance- home-care.html]. Accessed Feb 11, 2020.
  8. Chen, N., Zhou, M., Dong, X., et al. “Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.” Lancet 395 (2020): 507e13.
  9. Narang, K., Enninga, E.A.L., Gunaratne, M.D.S.K., et al. “SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review.” Mayo Clin Proc 95.8 (2020): 1750–65. DOI: 10.1016/j.mayocp.2020.05.011
  10. Laishuan, W., Yuan, S., Tiantian, X., et al. “Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection.” Ann Transl Med 8.3 (2020): 47. DOI: 10.21037/atm.2020.02.20
  11. Loeffelholz, M.J., Tang, Y.-W. “Laboratory diagnosis of emerging human coronavirus infections: the state of the art.” Emerg Microbes Infect 9.1 (2020): 747–56.
  12. Karimi-Zarchi, M., Neamatzadeh, H., Dastgheib, S.A., et. al. “Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review.” Fetal and Pediatric Pathology 39.3 (2020): 246–50. DOI: 10.1080/15513815.2020.1747120
  13. Royal College of Obstetricians & Gynecologists. Coronavirus (COVID-19) Infection in Pregnancy. Information for healthcare professionals (2020); Version 1: 63.
  14. Schwartz, D., Dhaliwal, A. “Infection in pregnancy with COVID-19 and other respiratory RNA virus diseases are rarely, if ever, transmitted to fetus: Experience with coronaviruses, HPIL, hMPV RSV and influenza.” Archives of Pathology & Laboratory Medicine (2020). DOI: 10.5858/arpa.2020-0211-SA
  15. Schwartz, D.A., Graham, A.L. “Potential maternal and infant outcomes from (Wuhan) Coronavirus 2019- nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections.” Viruses 12.2 (2020): 194. DOI: 10.3390/v12020194
  16. Smith, V., Seo, D., Warty, R., et al. “Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review.” PLOS One 15.6 (2020): e0234187. DOI: 10.1371/journal.pone.0234187
  17. Rasmussen, S.A., Smulian, J.C., Lednicky, J.A., et al. “Coronavirus Diseases 2019 (COVID-19) and pregnancy: what obstetricians need to know.” American Journal of Obstetrics & Gynecology 2020 May: 415–26. DOI: 10.1016/j.ajog.2020.02.017
  18. Vivanti, A.J., Vauloup-Fellous, C., Prevot, S., et al. “Transplacental transmission of SARS-CoV-2 infection.” Nat Commun 11.1 (2020): 3572. DOI: 10.1038/s41467-020-17436-6
  19. de Carvalho, W.B., Gibelli, M.A.B.C., Krebs, V.L.J. “Expert recommendations for the care of newborns of mothers with COVID-19.” Clinics (Sao Paulo) 75 (2020): e1932. DOI: 10.6061/clinics/2020/e1932
  20. World Health Organization. “Ukraine.” Available from: [https://www.who.int/countries/ukr/].
  21. Zhao, X., Jiang, Y., Zhao, Y., et al. “Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.” Eur J Clin Microbiol Infect Dis 39.7 (2020): 1209–20. DOI: 10.1007/s10096-020-03897-6
  22. Yudin, M.H., Steele, D.M., Sgro, M.D., et al. “Severe acute respiratory syndrome in pregnancy.” Obstetr Gynecol 105 (2005): 124–7. DOI: 10.1097/01.AOG.0000151598.49129.de
  23. Zeng, H., Xu, C., Fan, J., et al. “Antibodies in Infants Born to Mothers With COVID-19 Pneumonia.” JAMA 323.18 (2020): 1848–9. DOI: 10.1001/jama.2020.4861
  24. Zhao, S., Lin, Q., Ran, J., et al. “Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak.” Int J Infect Dis 92 (2020): 214e7.
  25. Zimmermann, P., Curtis, N. “COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiological and Clinical Features.” Pediatr Infect Dis J 39.6 (2020): 469–77. DOI: 10.1097/INF.0000000000002700




How to Cite

Beniuk, V., Hychka, N., Zabudskyi, O., Fursa-Sovhyra, T., Kovaliuk, T., Oleshko, V., & Chebotarova, A. (2021). Features of the pregnancy and delivery course, fetal and newborn status in women with COVID-19. REPRODUCTIVE ENDOCRINOLOGY, (61), 20–25. https://doi.org/10.18370/2309-4117.2021.61.20-25



Pregnancy and childbirth